Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07335640

Impact of an Information Sheet Given to Parents After an Initial Consultation for a Simple Febrile Seizure at Strasbourg University Hospital

Simple febrile seizures (SFS) are a very common phenomenon (2-5% of children), mostly without serious consequences for the child or their development, but extremely anxiety-provoking for parents, who develop a "fear of fever" for fear of a recurrence, and request numerous additional tests, not justified according to current guidelines, after a first episode of SFS.

Educating parents about these fever-related crises and fever management, and standardizing the information provided through an explanatory sheet implemented at the SAUP in July 2023, would help reduce consultations for recurrent simple febrile crises, as well as early consultations for isolated fever (reflecting parental anxiety caused by these crises).

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Febrile Crisis

Age range

9 month–5 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Service de pédiatrie 1 - CHU de Strasbourg - France

Strasbourg, 67091, France

Location status: Recruiting

Location contact

Catherine HEITZ, MD

PRINCIPAL_INVESTIGATOR

Dimitar TCHOMAKOV, MD

SUB_INVESTIGATOR

François SEVERAC, Statistician

SUB_INVESTIGATOR

Sarah Baer, MD

CONTACT

[email protected]

33 3 88 12 63 98

Sarah Baer, MD

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Child aged between 9 months and 5 years at the time of consultation at the SAUP (emergency pediatric unit)
  • First visit to the SAUP for a simple febrile seizure
  • Meeting the clinical criteria for FCS:
  • Generalized seizure lasting less than 15 minutes
  • No post-critical deficit
  • No recurrence of seizures within 24 hours
  • No personal history of neurological disorders
  • Occurrence between January 1, 2022, and May 1, 2025
  • First or second episode of FSFS at the time of consultation
  • Presence of one of the two parents during the consultation at the SAUP

Exclusion criteria

  • Patient already seen at the SAUP for FCS
  • Child who has already had more than two simple febrile seizures at the time of their visit to the emergency department.
  • Child who does not meet the criteria for simple febrile seizures:
  • aged less than 9 months or more than 5 years at the time of diagnosis.
  • Non-febrile seizure
  • Focal seizure
  • Seizure duration >15 min
  • Presence of post-critical deficit
  • Multiple seizures within 24 hours
  • Personal neurological history.
  • Seizure occurring outside the period of interest (January 1, 2022 to May 1, 2025)
  • Absence of parents during the SAUP consultation

Treatment and study plan

Primary outcomes

  1. Number of consultations at the Pediatric Emergency Department for recurrent simple febrile crises.

    Time frame: Up to 4 years

    Number of consultations at the Pediatric Emergency Department (SAUP) for recurrent simple febrile crises.

Study contacts

Contact information is provided by the study sponsor or research team.

Sarah Baer, MD

CONTACT

[email protected]

33 3 88 12 63 98

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Official study title

Impact d'Une Fiche Explicative donnée Aux Parents après Une première Consultation Pour Crise fébrile Simple au Service d'Accueil Des Urgences pédiatriques du CHU de Strasbourg

Acronym: ConvulStop

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jan 13, 2026
Registry last updated
Jan 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.